Here, we have picked three AI stocks, ADI, MU and MSFT, which are well-poised to benefit from AI's growing use and ability to solve complex problems.

Investors looking for stocks in the Banks - Foreign sector might want to consider either UBS (UBS) or Nu Holdings Ltd. (NU). But which of these two stocks offers value investors a better bang for their buck right now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Qiagen (QGEN) and Acadia Pharmaceuticals (ACAD). But which of these two stocks is more attractive to value investors?

Investors interested in Electronics - Miscellaneous Products stocks are likely familiar with TD SYNNEX (SNX) and Hoya Corp. (HOCPY). But which of these two stocks presents investors with the better value opportunity right now?

Paramount is reportedly looking for private-equity help with a possible $60 billion bid for Warner Bros., suggesting a deal may take longer than initially expected.

SAN FRANCISCO, Oct. 09, 2025 (GLOBE NEWSWIRE) -- A new securities class action lawsuit has been filed against KinderCare Learning Companies, Inc. (NYSE: KLC) and its executives, alleging the company misled investors during its October 2024 Initial Public Offering (IPO). The lawsuit, styled Gollapalli v. KinderCare Learning Companies, Inc., et al., seeks to represent investors who purchased KLC common stock in or traceable to the company's IPO.

The first interest rate cut of the year put fixed income investors on notice that the high-rate, high-yield environment they've been accustomed to is beginning to change. With that, emerging market (EM) bonds may be an option to consider when looking to diversify income and/or maximize yield potential.

SoundHound AI is at the forefront of the agentic AI transformation, driving enterprise adoption with its Amelia 7 platform. SOUN's recent deployment with Apivia Courtage showcases its ability to deliver significant productivity gains and compliance in highly regulated industries. The company's expanding enterprise partnerships, proprietary data accumulation, and network effects reinforce its long-term growth potential and platform moat.

NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Namib Minerals (“Namib Minerals” or “the Company”), (Nasdaq: NAMM), an established African Gold producer with a portfolio of mining and exploration assets in Zimbabwe and the Democratic Republic of Congo, is pleased to announce that it has re-engaged WSP, one of the world's leading professional services firms, to conduct comprehensive feasibility studies for the Company's Redwing and Mazowe Gold mining assets in Zimbabwe.

GS's Q3 results are set for Oct. 14, with solid IB growth and market volatility expected to have driven its performance despite rising expenses.

CHWY's robust Q2 results, record Autoship growth and higher sales outlook highlight its strength amid rising costs and competition.

Scorpion Capital alleged Soleno's sole product, Vykat XR, was overpriced and unsafe for children, causing shares to drop 7.4% to $71.63 on August 15, 2025.

S&P Global remains undervalued amid AI-driven market pessimism, despite strong fundamentals and resilient revenue growth across key business segments. AI is unlikely to replace SPGI's core businesses, as human judgment, reputation, and regulatory barriers maintain the company's dominance in ratings and indices. AI can serve as a growth catalyst for SPGI by enhancing operational efficiency, not as a disruptive threat to its business model or client trust.

Mohawk Industries remains attractively valued but faces ongoing revenue and profit pressure amid soft demand and macroeconomic headwinds. MHK's Q2 revenue was flat year-over-year, with gains from pricing and currency offsetting volume declines; segment performance was mixed. Despite aggressive cost-cutting and restructuring, adjusted net profits and cash flows continue to decline, signaling persistent near-term challenges.

AstraZeneca broke ground on a new plant in Virginia on Thursday and said it would spend $4.5 billion on the facility as drugmakers look to respond to President Donald Trump's call for more medicines to be made in the U.S. and at lower costs.

C is set to post Q3 results, with expected gains in revenues, earnings and investment banking momentum.

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

Synopsys (SNPS) reported earnings 30 days ago. What's next for the stock?

Delta executives say they expect premium revenue from first class and other higher-priced cabins to overtake the coach cabin next year. In the last quarter, Delta said ticket revenue from its premium cabin rose 9% from last year to nearly $5.8 billion.

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca today announces that it will invest $4.5 billion in its new manufacturing facility in Virginia, a proposed increase of $500m to support the enhanced manufacturing capability of a broader range of medicines including cancer treatments. This is part of the historic $50 billion investment announced in July 2025. The new facility will be located at Rivanna Futures in Albemarle County and is expected to create approximately 3,600 direct and indirect job.